Abstract
The evolution of entry criteria in clinical trials of autologous haematopoietic stem cell transplantation for relapsing remitting multiple sclerosis to reflect changing clinical practice
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
